Dasatinib + Blinatumomab Active for Ph-Positive ALL in Adults
THURSDAY, Oct. 22, 2020 (HealthDay News) — Chemotherapy-free induction and consolidation...
Read More
Pharmacy
U.S. COVID-19 Vaccine Trial Enrolls 30,000
THURSDAY, Oct. 22, 2020 (HealthDay News) — The first company to start a phase 3 trial of a...
Read More
PrEP Prescribing Low in the U.S., Even Among HIV Care Providers
Even among HIV-focused practitioners, preexposure prophylaxis (PrEP) prescribing is not routine,...
Read More
Purdue Pharma to Plead Guilty to Opioid-Related Crimes
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Purdue Pharma, maker of the opioid painkiller...
Read More
Fauci ‘Cautiously Optimistic’ for COVID-19 Vaccine by Year’s End
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Anthony Fauci, M.D., the leading infectious...
Read More
Vaccine Attributes Influence Readiness to Accept COVID-19 Shot
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Vaccine-related attributes and political...
Read More
CDC: 65.3 Percent of U.S. Women Currently Using Contraceptives
TUESDAY, Oct. 20, 2020 (HealthDay News) — In 2017 to 2019, 65.3 percent of women aged 15 to...
Read More
Investigational Drug May Prolong Survival in Patients With ALS
TUESDAY, Oct. 20, 2020 (HealthDay News) — Long-term survival analysis shows that patients...
Read More
No COVID-19 Vaccines Allowed in California Without State Approval
TUESDAY, Oct. 20, 2020 (HealthDay News) — California is not going to allow the use of any...
Read More
Scientists to Infect Volunteers With COVID-19 in Challenge Trial
TUESDAY, Oct. 20, 2020 (HealthDay News) — British scientists are infecting healthy...
Read More
Anti-VEGF Therapy May Aid Visual Acuity in Some nAMD Patients
MONDAY, Oct. 19, 2020 (HealthDay News) — For about 20 percent of patients with neovascular...
Read More
Inactivated SARS-CoV-2 Vaccine Well Tolerated in Phase 1/2 Trial
MONDAY, Oct. 19, 2020 (HealthDay News) — An inactivated severe acute respiratory syndrome...
Read More
No Pfizer COVID-19 Vaccine Expected Before Election
MONDAY, Oct. 19, 2020 (HealthDay News) — Pfizer will not apply for emergency authorization...
Read More
Use of Common Meds Tied to Lower Lung Cancer Mortality
FRIDAY, Oct. 16, 2020 (HealthDay News) — Use of aspirin, metformin, and statins is...
Read More
Outcomes Worse for Women With MI at 50 Years or Younger
FRIDAY, Oct. 16, 2020 (HealthDay News) — Women who experience their first myocardial...
Read More
Pharmacotherapy, Psychotherapy Combo Best for Bipolar Disorder
FRIDAY, Oct. 16, 2020 (HealthDay News) — Manualized psychotherapy interventions combined...
Read More
Upadacitinib Tops Abatacept for RA Refractory to DMARDs
FRIDAY, Oct. 16, 2020 (HealthDay News) — Upadacitinib is superior to abatacept for patients...
Read More
FDA Requiring Labeling Changes to NSAIDs Warning of Risks in Pregnancy
FRIDAY, Oct. 16, 2020 (HealthDay News) — The U.S. Food and Drug Administration is requiring...
Read More
Polypharmacy Common in Seniors With Heart Failure
THURSDAY, Oct. 15, 2020 (HealthDay News) — Polypharmacy, defined as taking 10 or more...
Read More
Cannabinoid Use Tied to Adverse Outcomes With COPD
THURSDAY, Oct. 15, 2020 (HealthDay News) — New cannabinoid use is associated with elevated...
Read More